Brief: Medivir Partner Infex Therapeutics Receives FDA QIDP Designation

Medivir AB

11/01/2023 07:33

Jan 11 (Reuters) - Medivir AB  MVIRb.ST :
    * MEDIVIR PARTNER INFEX THERAPEUTICS RECEIVES FDA QIDP
DESIGNATION
    * INFEX THERAPEUTICS HAS BEEN GRANTED QUALIFIED INFECTIOUS
DISEASE
PRODUCT (QIDP) DESIGNATION FOR MET-X BY U.S. FOOD AND DRUG
ADMINISTRATION (FDA)
    * MEDIVIR IS ENTITLED TO SHARE OF POTENTIAL FUTURE REVENUES
FROM
MET-X PROGRAMME

Source text for Eikon:  ID:nWkr8BPtxq 
Further company coverage:  MVIRb.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))